Literature Radar · Free weekly digest
New research across every source, curated for the topics you actually work on.
We poll Europe PMC (PubMed + PMC + preprints from bioRxiv / medRxiv / arXiv) and OpenAlex (250M works — 7× wider than PubMed) every day. You get one Monday digest — no marketing copy — with source and free-full-text signals on every paper.
Or browse all 2219 approved papers →
Latest research
The most recent additions across all topics.
- Open Access CRIS of the University of Bern · 2026· Cyclotron production· Free full textCross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications.
- European journal of nuclear medicine and molecular imaging · 2026· Ac-225 alpha therapyTargeted alpha therapy for recurrent high-grade glioma with [²²⁵Ac]-PSMA: a new theranostic approach.
- EJNMMI reports · 2026· I-131 therapyFuture scenarios of radioligand therapy in pheochromocytomas and paragangliomas.
- Bioconjugate chemistry· Cyclotron production· Free full text“Imaging Triplets on Two Wheels”: 61Cu‑, 64Cu‑, and 68Ga-labeled Bicyclic Peptides Targeting Nectin‑4 Enable High-Contrast PET Imaging of Urothelial Carcinoma and Triple-Negative Breast Cancer
- European journal of nuclear medicine and molecular imaging · 2026· Ga-68 PSMA PETHead-to-head comparison of [¹⁸F]F-PSMA-1007 PET/CT and [⁶⁸Ga]Ga-PSMA-11 PET/CT for intraprostatic tumour detection and localisation using histopathology as reference: A prospective single-centre diagnostic accuracy study.
- Cell death discovery · 2026· Lu-177 DOTATATE· Free full textImmunogenic cell death as a mechanism of synergy between sunitinib and ¹⁷⁷Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors.
- Insights into imaging · 2026· Free full textPost-therapy imaging of adult brain tumours: patterns, pitfalls, and practical framework.
- Medical dosimetry : official journal of the American Association of Medical Dosimetrists · 2026· Patient-specific QA· Free full textEffects of grid size and statistical uncertainty parameters on dose calculations using the Monte Carlo algorithm in the Monaco treatment planning system for liver stereotactic body radiotherapy.
- Journal of neuro-oncology · 2026· SRS / intracranial· Free full textReirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.
- Journal of applied clinical medical physics · 2026· SRS / intracranial· Free full textEvaluation of interfractional shift corrections in Gamma Knife radiosurgery
- Journal of applied clinical medical physics · 2026· Patient-specific QA· Free full textCommissioning and end‐to‐end validation of a combined surface‐guided and triggered kV imaging workflow for breath‐hold SBRT on a Varian TrueBeam
- Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2026· Adaptive radiotherapy· Free full textFeasibility of prostate offline adaptive radiation therapy using iterative reconstructed CBCT to optimize the ART workflow.
- Cancer science · 2026· SBRT delivery· Free full textAdvances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer.
- Academic radiology · 2026· Ga-68 DOTATATE· Free full textPredicting Response to Somatostatin Analog Therapy in GEP-NET Liver Metastases: A Machine Learning Approach with ⁶⁸Ga-DOTATATE and ¹⁸F-FDG PET/CT.
- BMJ open · 2026· Ga-68 PSMA PET· Free full textCan early ⁶⁸Ga-PSMA-11 PET/CT predict 6-month disease control in patients receiving first-line systemic therapy for metastatic clear-cell renal cell carcinoma? Protocol for the multicentre prospective phase II PSMA-RENAL study in Belgium.
- Cureus· SBRT delivery· Free full textPalliative Stereotactic Body Radiotherapy for Metastatic Clear Cell Sarcoma: A Case Report
- Frontiers in immunology· SRS / intracranial· Free full textComplete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review
- Frontiers in oncology· SRS / intracranial· Free full textSurgical resection with postoperative stereotactic radiosurgery versus stereotactic radiosurgery alone for large (>3 cm) multiple brain metastases: a propensity score-matched analysis
- Frontiers in oncology· Breast / lung positioning· Free full textBeyond the snapshot: continuous optical surface monitoring reveals non-linear temporal dynamics and postural stability window in free-breathing breast radiotherapy
- Frontiers in cell and developmental biology· Free full textEarly diagnosis of radiation-induced renal injury: from lagging indicators to multimodal, pre-fibrotic detection
- Journal of nuclear medicine · 2026· Cyclotron productionBeta Atlas: Charting Global Production of Nonconventional β--Emitters for Targeted Radiopharmaceutical Therapy-Part 1.
- Physica medica · 2026· TLD dosimetryDosimetry with LIF:Mg,Ti (TLD-100) for locating non-paubable breast cancer using Iodine-125 seeds.
- Cancer treatment and research communications · 2026· Ra-223Radium-223 alters the levels of soluble immune regulators in the plasma of patients with metastatic castrate-resistant prostate cancer.
- The EANM Journal · 2026· Free full textRegulatory and organisational barriers to non-commercial clinical trials in European nuclear medicine: Results from an EANM survey
Browse papers by topic
27 topics across 5 product families. Pick a topic to read every approved paper in it.
Theranostics
Lu-177 PSMA-617 / PSMA-I&T evidence — VISION, PSMAfore, dosimetry, salivary-gland and kidney safety.
PRRT evidence for neuroendocrine tumours — NETTER-1 / NETTER-2 / NETTER-P / first-line questions.
FAP-targeted radioligand therapy — pancreatic, sarcoma, breast, head-and-neck investigational evidence.
Ga-68 PSMA-11 / -617 PET imaging — selection, biochemical-recurrence detection, intra-prostatic mapping.
Ga-68 SSTR imaging — neuroendocrine staging, PRRT eligibility and dosimetric pairing with Lu-177.
Alpha-therapy in bone-metastatic mCRPC — ALSYMPCA legacy, sequencing with Lu-177 PSMA, and updated guidance.
Targeted alpha therapy — Ac-225 PSMA and DOTATATE clinical experience, supply and dosimetry.
I-131 thyroid-cancer ablation evidence — activity selection, recurrence imaging, hospital-discharge practice.
Radiotherapy QA
Machine QA — TG-142 / MPPG 9.a recalibration, daily / monthly / annual practice, flatness-symmetry trends.
Pre-treatment verification — IMRT/VMAT gamma analysis, log-file QA, 3D dose reconstruction.
SBRT outcomes + protocol updates — per-site evidence for lung, liver, prostate, pancreas, spine, oligomets.
Intracranial SRS — single-iso multi-met, frame-vs-frameless, rotational-correction studies.
MR-linac clinical and physics evidence — on-table adaptation, gating, daily-online plan adapt.
Adaptive RT workflows — Ethos / Halcyon, plan-of-the-day, CBCT-driven online replanning.
Patient Immobilization
Head-and-neck masks — reproducibility, intrafraction motion, SRS frame-mask choices.
Vacuum-bag immobilisation reproducibility for SBRT, lung, abdomen, pelvis and whole-body workflows.
Per-site SBRT setup — body frame, abdominal compression, knee + ankle support reproducibility.
Tangential breast IMRT, DIBH heart-sparing, prone breast and combined breast-and-nodal positioning.
3DoF / 6DoF head adjusters that close the rotational gap on bore-class linacs — pitch / roll / yaw correction studies.
Soft-tissue fiducial markers for IGRT — prostate, liver, lung, pancreas. Anchoring vs migration evidence.
Dosimetry
OSL chip characterisation, in-vivo evidence, TBI / TSET, energy and angular response, nanoDot replacements.
TLD personal-dosimetry evidence — material chemistry, reader response, in-vivo and extremity work.
TG-191 in-vivo dosimetry programmes — IMRT/VMAT routine practice, TBI / TSET, special techniques.
Whole-body and extremity dosimetry for nuclear-medicine, interventional and theranostic staff.
Hot-Lab QC
Per-batch release testing — radio-TLC, radio-HPLC, %RCP, USP 823, Eur.Ph. breakthrough monographs.
Hot-cell and dispensing-bench shielding — fume hood vs laminar flow, β/γ hybrid for Lu-177 / Y-90 work.
Cyclotron F-18 synthesis, Ga-68 generator chemistry, theranostic radionuclide production logistics.
Recent papers for the topics you picked
Almost done.
Please open the confirmation email we just sent. One click confirms every topic you picked. The first digest reaches you on the next Monday morning.